SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma

24Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. No satisfactory biomarkers are currently available to screen for nasopharyngeal carcinoma (NPC). We have developed and evaluated surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for detection and analysis of multiple proteins for distinguishing individuals with NPC from control individuals. Methods. A preliminary learning set and a classification tree of spectra derived from 24 patients with NPC and a group of 24 noncancer controls were used to develop a proteomic model that discriminated cancer from noncancer effectively. Then, the validity of the classification tree was challenged with a blind test set, which included another 20 patients with NPC and 12 noncancer controls. Results. A panel of 3 biomarkers ranging m/z 320 k was selected to establish Decision Tree model by BPS with sensitivity of 91.66% and specificity of 95.83%. The ability to detect NPC patients was evaluated, a sensitivity of 95.0% and specificity of 83.33% were validated in blind testing set. Conclusion. This high-flux proteomic classification system will provide a highly accurate and innovative approach for the detection/diagnosis of NPC. © 2009 Huang et al.

Cite

CITATION STYLE

APA

Huang, Y. J., Xuan, C., Zhang, B. B., Liao, M., Deng, K. F., He, M., & Zhao, J. M. (2009). SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. Journal of Experimental and Clinical Cancer Research, 28(1). https://doi.org/10.1186/1756-9966-28-85

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free